Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR3 | P32745 | 1/20 | 0.33 |
| ▸ | AXL | P30530 | 12/20 | 0.33 |
| ▸ | MERTK | Q12866 | 11/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.31 |
| ▸ | CSF1R | P07333 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9287104 | 0.92 | PDE1A (0.34) | AXLMERTKPPARDPPARAPIK3CA | |
| SCHEMBL11963683 | 0.79 | PPARA (0.34) | SSTR3AXLMERTKPPARARAB9A | |
| SCHEMBL1652645 | 0.73 | NPC1 (0.31) | NPC1RAB9A | |
| SCHEMBL1652175 | 0.73 | PARP14 (0.38) | — | |
| SCHEMBL12239371 | 0.73 | NPC1 (0.36) | NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL11963670 | 0.73 | MEN1 (0.32) | — | |
| SCHEMBL11963678 | 0.71 | AXL (0.31) | AXLMERTKNPC1RAB9A | |
| SCHEMBL1160649 | 0.71 | PDE1A (0.36) | PPARDPPARANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL12239272 | 0.71 | KDM1A (0.35) | HPGDLMNAHTT | |
| SCHEMBL12239271 | 0.71 | CSF1R (0.38) | AXLCSF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9051300-B2 | Herbicides | SYNGENTA LIMITED (GB) | 2015-06-09 | — | — | US | disclosed |
| US-20120202691-A1 | NOVEL HERBICIDES | SYNGENTA CROP PROTECTION LLC (US) | 2012-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120202691-A1 | NOVEL HERBICIDES | DDT, HCN1, HDHD5 | SSTR3 826/4885AXL 2796/4885MERTK 4150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.